Erythromycin Panpharma

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin;  

Disponível em:

Multichem NZ Limited

Dosagem:

1 g

Forma farmacêutica:

Powder for infusion

Composição:

Active: Erythromycin lactobionate 1.49 g equivalent to 1 g erythromycin  

Tipo de prescrição:

Prescription

Indicações terapêuticas:

Upper respiratory tract infections caused by Streptococcus pyogenes (Group A beta haemolytic streptococci); Lower respiratory tract infections caused by Streptococcus pyogenes (Group A betahaemolytic streptococci); Skin and skin structure infections caused by Streptococcus pyogenes.

Resumo do produto:

Package - Contents - Shelf Life: Vial, glass, 20 mL glass vial type III, in a cardboard carton - 1 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 10 dose units - 3 years from date of manufacture stored at or below 30°C protect from light - Vial, glass, 20 mL glass vial type III, in a cardboard carton - 25 dose units - 3 years from date of manufacture stored at or below 30°C protect from light

Data de autorização:

2017-08-14